Products
AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Free
No monthly subscription pricing
Creators
Mateusz Misztoft
@mat_misztoft· 272 followers
Launched
6y ago
2020-06-24 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
X accounts@mat_misztoft@mixon00

  • Launched on Product HuntLaunch

    COVID-19 CLI tracking tool

    Jun 24, 2020 · 6y agoLaunch page

Open Source & Agent Ecosystem

GitHub · MCP / Skill
mat-misztoft/cov19-cli
GitHub Stars
Public repo
Forks
—
License
See repository
Primary language
—
Browse peer open-source projects →

Agent, MCP & Developer Integration

CLI / SDK
Integration docs
Exposed tool capabilities:
Infectious Disease DataShow detailed statsAdd to favouritesRemove from favouritesLimit displayed results
Browse developer & CLI tools →

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 1996-06-26

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2020-06-24

Key pages

Weekly snapshots

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does Cov19 get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Cov19 and what platforms does it support?
Cov19 is catalogued under Data APIs & Datasets: COVID-19 CLI Tool. Supported platforms: CLI / SDK.
Is Cov19 open source?
Cov19 has a public repository (https://github.com/mat-misztoft/cov19-cli) with its source repository published.Source

Related products in this category

Data & Analytics / Data APIs & Datasets

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.